Shorter Gene Therapy Postmarket Studies ‘On The Table’

 
• By Derrick Gingery
  
Natural history or other data could help the FDA shorten gene therapy follow-up times. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Rare Diseases